Ditracon Tablets (Itraconazole Solid Dispersion)

Adult dose

Administration immediately after a meal is preferable. Candida vaginitis: Administer itraconazole 200 mg twice daily (morning and evening) for 1 day, or 200 mg once daily for 3 days. Tinea versicolor: Administer 200 mg once daily for 7 days. Tinea corporis, tinea cruris: Administer 100 mg once daily for 15 days. Tinea manuum (interdigital), tinea pedis (interdigital): Administer 100 mg once daily for 15 days. Tinea manuum (palmar), tinea pedis (plantar): Administer 100 mg once daily for 30 days or 200 mg twice daily for 7 days. Oral candidiasis: Administer 100 mg once daily for 15 days. Fungal keratitis: Administer 200 mg once daily for 21 days. Intermittent treatment for onychomycosis: Administer 200 mg twice daily for 1 week, followed by a 3-week drug-free period; this constitutes 1 cycle. Administer up to 2 cycles for infection of the fingernails only and up to 3 cycles for infection of the toenails. Continuous treatment for onychomycosis: Administer 200 mg once daily for 3 months. In patients with impaired immune function, such as those with neutropenia or AIDS, or organ transplant recipients, the oral bioavailability of this drug may be reduced; if necessary, double the dose. Aspergillosis: 200mg once daily for 2～5 months. For invasive or disseminated disease, increase the dose to 200mg twice daily. Candidiasis: 100～200mg once daily for 3 weeks～7 months. Cryptococcal meningitis: 200mg twice daily for 2 months～1 year. Maintenance therapy: 200mg once daily. Paracoccidioidomycosis: 100mg once daily for 6 months.

This medication should not be used in patients with impaired cardiac function, particularly those with congestive heart failure, unless specifically indicated. If symptoms of heart failure develop during use, discontinue immediately. Patients allergic to this medication should not use it, and it should also not be administered in cases of specific heart diseases or for purposes other than treating severe infections. Additionally, this medication may interact with various drugs, so if you are taking other medications, be sure to consult your doctor or pharmacist. Pregnant or potentially pregnant women and breastfeeding mothers should not use this medication, nor should it be administered to patients with lactose intolerance. Patients with impaired liver or kidney function should use this medication cautiously, as it may affect metabolism and excretion, and regular liver function tests should be conducted. Caution is also necessary for patients with weakened immune systems or specific neurological disorders. Symptoms such as headache, nausea, abdominal pain may occur during the use of this medication, and in rare cases, serious allergic reactions, liver damage, or skin rashes may occur. This medication can affect heart rhythm or blood pressure, so report any unusual symptoms to a healthcare professional immediately. Dizziness or vision disturbances may occur when driving or operating machinery, so caution is advised. In case of overdose, there is no specific antidote, so seek appropriate medical treatment immediately. Special precautions should be taken when using this medication in children or elderly patients, or those with liver or kidney dysfunction. Finally, store this medication in its original container and keep it out of reach of children.

Headache, nausea, abdominal pain, rhinitis, sinusitis, upper respiratory tract infection, leukopenia, hypersensitivity, taste disorder, sensory impairment, sensory abnormality, tinnitus, constipation, diarrhea, indigestion, bloating, vomiting, liver dysfunction, hyperbilirubinemia, itching, rash, urticaria, pollakiuria, erectile dysfunction, menstrual disorders, edema, neutropenia, thrombocytopenia, anaphylaxis-like reaction, hyperglycemia, hyperkalemia, hypokalemia, hypomagnesemia, confusion, peripheral neuropathy, dizziness, drowsiness, tremor, heart failure, left ventricular failure, tachycardia, hypertension, hypotension, pulmonary edema, speech disorder, cough, gastrointestinal disturbance, liver failure, hepatitis, jaundice, erythematous rash, sweating, myalgia, arthralgia, renal impairment, urinary incontinence, generalized edema, facial edema, chest pain, fever, pain, fatigue, chills, leukocytosis, eosinophilia, anemia, vascular edema, serum sickness, angioedema, anaphylaxis, anaphylactic shock, allergic reaction, diplopia, visual impairment, temporary or permanent hearing loss, ventricular extrasystole, atrioventricular block, palpitations, increased bowel motility, belching, glossitis, stomatitis, abdominal and lumbar pain, pancreatitis, elevated serum total protein, elevated total bilirubin, increased LAP, anorexia, malaise, dark urine, elevated liver enzyme levels, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, erythema multiforme, hair loss, photosensitivity reaction, exfoliative dermatitis, leukocyte destructive vasculitis, acute generalized exanthematous pustulosis, increased BUN, positive urinary protein, positive urinary glucose, decreased libido, drowsiness, shoulder stiffness, insomnia, chest pain, elevated serum triglycerides, burning sensation, elevated serum uric acid levels, elevated serum potassium levels, serum sickness, angioedema, anaphylactic reaction, hypertriglyceridemia, tremor, visual impairment, congestive heart failure, dyspnea, significant hepatotoxicity, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, increased serum creatine phosphokinase levels

This medication should be stored in a tightly sealed container to prevent air ingress and preferably kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain its efficacy and prevents deterioration.

Appearance

White or pale yellow round film-coated tablet

Package unit

28 tablets/bottle, 100 tablets/bottle